The chemical substance known as (S)-2-((S)-4-Methyl-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid, with the CAS number 2049024-77-1, is a complex organic compound characterized by its chiral centers and multiple functional groups. This compound features an amino acid backbone, which is indicative of its potential biological activity, particularly in pharmaceutical applications. The presence of a morpholino group suggests that it may interact with biological systems, possibly influencing protein synthesis or receptor activity. The compound's stereochemistry, denoted by the (S) and (R) configurations, is crucial for its biological function, as the spatial arrangement of atoms can significantly affect its interaction with biological targets. Additionally, the presence of aromatic rings and amide linkages contributes to its stability and solubility properties. Overall, this compound exemplifies the complexity often found in drug design, where specific structural features are tailored to enhance efficacy and reduce side effects in therapeutic contexts.

(S)-2-((S)-4-Methyl-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid

2049024-77-1: The chemical substance known as (S)-2-((S)-4-Methyl-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid, with the CAS number 2049024-77-1, is a complex organic compound characterized by its chiral centers and multiple functional groups. This compound features an amino acid backbone, which is indicative of its potential biological activity, particularly in pharmaceutical applications. The presence of a morpholino group suggests that it may interact with biological systems, possibly influencing protein synthesis or receptor activity. The compound's stereochemistry, denoted by the (S) and (R) configurations, is crucial for its biological function, as the spatial arrangement of atoms can significantly affect its interaction with biological targets. Additionally, the presence of aromatic rings and amide linkages contributes to its stability and solubility properties. Overall, this compound exemplifies the complexity often found in drug design, where specific structural features are tailored to enhance efficacy and reduce side effects in therapeutic contexts.

CAS 2049024-77-1

(S)-2-((S)-4-Methyl-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid

Carfilzomib Impurity 45

Ref: 4Z-C-121048

Carfilzomib Impurity 63

Ref: ST-EA-CP-C153054